A single multicenter trial was conducted using talactoferrin in 750–1500 g neonates, which examined 120 infants and showed a trend towards decreased infectious morbidity but did not achieve statistical significance [ 125 ] ( Table 1 ).
1
—
—
A single multicenter trial was conducted using talactoferrin in 750–1500 g neonates, which examined 120 infants and showed a trend towards decreased infectious morbidity but did not achieve statistical significance [ 125 ] ( Table 1 ).